Robust & Flexible Cell Lines That Fit Your Strategy

For any new complex biologic, establishing a robust, high-yielding cell line is the cornerstone of a successful path to IND. Yet cell line development (CLD) is rarely straightforward — it is a technically demanding, multi-dimensional process that requires deep expertise, seamless integration, and flawless execution.

At Abzena, we bring over two decades of CLD experience together with state-of-the-art technologies to ensure every step is strategically designed and meticulously executed. Our approach not only addresses the unique requirements of each biologic but also de-risks and streamlines the journey to the clinic.

Our proprietary AbZelectPRO™ platforms deliver higher productivity, accelerated timelines, and proven performance — without the burden of royalties or exit fees. By leveraging integrated partnered technologies with Revvity and ProteoNic Biosciences, we enable rapid, high-performing workflows that take you from DNA to research cell bank (RCB) generation in as little as 10 weeks, achieving titers of up to 10 g/L.

With Abzena, sponsors gain a future-ready CLD solution that combines speed, scalability, and reliability — ensuring your biologic is set up for long-term success.